Pulse Biosciences up as FDA approves expanded settings for skin device

Pulse Biosciences

04/08/2022 16:21

** Shares of medical device maker Pulse Biosciences  PLSE.O 
rise 7.5% to $1.71
    ** Co says U.S. FDA has cleared expanded energy settings for
use with its CellFX system  urn:newsml:reuters.com:*:nBw5Z8LLXa
    ** CellFX system delivers nano-pulse stimulation to clear
benign skin lesions
    ** Clinicians in U.S. are now able to access broader
treatment settings to provide more customized energy delivery
specific to individual lesions - CEO
    ** Stock down ~88% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com;))